The Amyloidosis Channel is supported with funding from Prothena (Silver).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ISA 2024 | Challenges in distinguishing AL amyloidosis from ATTR amyloidosis
In this video, Olga Gursky, PhD, Boston University, Boston, MA, discusses challenges in diagnosing light chain (AL) amyloidosis versus transthyretin (ATTR) amyloidosis. Risky organ biopsies are often needed for accuracy, though noninvasive methods like radioactive tracer uptake can be used as an alternative. The role of calcification and amyloid fibril structures in diagnosis are also explored. This interview took place at the XIX International Symposium on Amyloidosis (ISA) in Rochester, MN.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
